The U.S. continues to charge significantly higher prices for prescription drugs compared to similarly wealthy countries.
More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...
While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...
PBMs demand discounts and rebates from drugmakers, which leads the manufacturers to charge higher list prices ... who launched Mark Cuban Cost Plus Drugs in 2022 to upend the byzantine $500 billion ...
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.